Product Information
QC ANTI-DIARRHEAL 2 MG CAPLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.1299 per EA under NDC 83324006412. Its NADAC has been published 87 times since Feb 5, 2025.
FDA first approved this application on Jun 10, 2003.
Strength
2 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324006412
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LOPERAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076497FDA Approved
6/10/2003
On Market Since
6/17/2024
Pharmacological Classes
Price Statistics
The NADAC for QC ANTI-DIARRHEAL 2 MG CAPLET has been published 87 times since Feb 5, 2025, and over the history we have for it it has declined 2.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1299 per EA |
|---|---|
| All-time high | $0.1465 (Nov 12, 2025) |
| All-time low | $0.1233 (Apr 22, 2026) |
| 52-week high | $0.1465 |
| 52-week low | $0.1233 |
| Median price | $0.1320 |
| Average price | $0.1340 |
| Largest weekly change | -5.0% (Jan 21, 2026) |
| Weeks tracked | 87 |
| Tracking since | Feb 5, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Loperamide HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC ANTI-DIARRHEAL 2 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for QC ANTI-DIARRHEAL 2 MG CAPLET, manufactured by Chain Drug Marketing Association, is $0.1299 per EA (NDC 83324006412), effective Sep 30, 2026.
How has the price of QC ANTI-DIARRHEAL 2 MG CAPLET changed over time?
Over the history we have for it, the NADAC for QC ANTI-DIARRHEAL 2 MG CAPLET has declined 2.1%. It has been tracked across 87 weekly CMS publications since Feb 5, 2025.
What are the highest and lowest recorded NADAC prices for QC ANTI-DIARRHEAL 2 MG CAPLET?
Since Feb 5, 2025, the NADAC for QC ANTI-DIARRHEAL 2 MG CAPLET has ranged from a low of $0.1233 (Apr 22, 2026) to a high of $0.1465 (Nov 12, 2025), with a median of $0.1320 per EA.
Are there cheaper alternatives to QC ANTI-DIARRHEAL 2 MG CAPLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as QC ANTI-DIARRHEAL 2 MG CAPLET in a comparable dosage form, but none are currently priced below it.
Who manufactures QC ANTI-DIARRHEAL 2 MG CAPLET?
QC ANTI-DIARRHEAL 2 MG CAPLET (NDC 83324006412) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.